Breast Cancer News

SAN ANTONIO — Use of pembrolizumab with neoadjuvant chemotherapy and as monotherapy in the adjuvant setting provided a durable EFS benefit for patients with early-stage triple-negative breast cancer, according to study results.

Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.

To help individuals who undergo cancer treatment lead healthier lives, Stacyann Bailey, PhD, has one overarching professional mission — to prevent bones from breaking.

The treatment landscape for metastatic breast cancer has evolved tremendously within the past 2 decades.

Multinational Association of Supportive Care in Cancer published the first set of consensus guidelines intended to prevent lymphedema among patients who underwent surgery for breast cancer.

SAN ANTONIO — A four-therapy combination conferred clinical benefit to nearly all evaluable patients with metastatic triple-positive breast cancer, according to findings of the ASPIRE trial presented at San Antonio Breast Cancer Symposium.

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.

U.S. policies built around racism and persistent discrimination impact modern-day breast cancer outcomes, with worse outcomes for women living in historically redlined areas, according to study findings published in JAMA Network Open.

Women with unmet social needs are significantly less likely to undergo breast cancer screening and to have later-stage cancer at diagnosis even when free mammography is available, according to study results published in JAMA Network Open.

A woman in her late 50s is currently receiving treatment for her second bout of breast cancer. She is thought to be in remission, but Neelam Desai, MD, worries about more than just the disease.